Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Bradley Irwin Sells 4,300 Shares of Church & Dwight (NYSE:CHD) Stock

Дата публикации: 12-08-2026 17:08:47

Church & Dwight Co., Inc. (NYSE:CHD – Get Free Report) Director Bradley Irwin sold 4,300 shares of the business’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $102.69, for a total value of $441,567.00. Following the completion of the sale, the director directly owned 35,674 shares […]

Основное содержимое страницы с новостью.

Posted by Tristan Rich on Aug 12th, 2026

Church & Dwight logoChurch & Dwight Co., Inc. (NYSE:CHDGet Free Report) Director Bradley Irwin sold 4,300 shares of the business’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $102.69, for a total value of $441,567.00. Following the completion of the sale, the director directly owned 35,674 shares of the company’s stock, valued at $3,663,363.06. The trade was a 10.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Church & Dwight Stock Down 0.9%

CHD stock traded down $0.91 during trading on Wednesday, reaching $101.87. 375,494 shares of the stock were exchanged, compared to its average volume of 2,130,360. The firm’s 50 day moving average is $98.00 and its 200 day moving average is $97.27. The firm has a market cap of $24.16 billion, a P/E ratio of 32.76, a price-to-earnings-growth ratio of 3.77 and a beta of 0.47. The company has a current ratio of 1.15, a quick ratio of 0.69 and a debt-to-equity ratio of 0.51. Church & Dwight Co., Inc. has a twelve month low of $81.33 and a twelve month high of $106.04.

Church & Dwight (NYSE:CHDGet Free Report) last announced its quarterly earnings data on Friday, July 31st. The company reported $0.89 EPS for the quarter, missing analysts’ consensus estimates of $0.90 by ($0.01). Church & Dwight had a net margin of 11.96% and a return on equity of 20.10%. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same period last year, the business posted $0.94 EPS. The company’s revenue was up 1.6% on a year-over-year basis. Church & Dwight has set its Q3 2026 guidance at 0.890-0.890 EPS and its FY 2026 guidance at 3.740-3.810 EPS. As a group, research analysts forecast that Church & Dwight Co., Inc. will post 3.78 EPS for the current year.

Church & Dwight Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Friday, August 14th will be issued a dividend of $0.3075 per share. The ex-dividend date is Friday, August 14th. This represents a $1.23 annualized dividend and a yield of 1.2%. Church & Dwight’s dividend payout ratio is presently 39.55%.

Institutional Trading of Church & Dwight

Several institutional investors and hedge funds have recently made changes to their positions in the company. Farringdon Capital Ltd. bought a new position in shares of Church & Dwight during the second quarter valued at about $243,000. Varma Mutual Pension Insurance Co bought a new stake in Church & Dwight in the 2nd quarter worth about $9,795,000. Westpac Banking Corp bought a new stake in Church & Dwight in the 2nd quarter worth about $229,000. Sumitomo Life Insurance Co. purchased a new stake in Church & Dwight in the 2nd quarter valued at about $441,000. Finally, Korea Investment CORP purchased a new stake in Church & Dwight in the 2nd quarter valued at about $11,142,000. Hedge funds and other institutional investors own 86.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on CHD. Wall Street Zen cut shares of Church & Dwight from a “hold” rating to a “sell” rating in a report on Saturday. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $109.00 target price on shares of Church & Dwight in a report on Monday, May 4th. Wells Fargo & Company reiterated an “overweight” rating and set a $110.00 price target (up from $105.00) on shares of Church & Dwight in a research note on Wednesday, July 8th. Morgan Stanley set a $112.00 price objective on Church & Dwight in a report on Monday, August 3rd. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $111.00 price objective on shares of Church & Dwight in a research note on Friday, May 29th. Nine research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $104.41.

Read Our Latest Stock Report on CHD

About Church & Dwight

(Get Free Report)

Church & Dwight Co, Inc is a U.S.-based consumer products company best known for its Arm & Hammer baking soda business. Founded in 1846 with the manufacture and marketing of sodium bicarbonate, the company has grown into a diversified maker and marketer of household, personal care and specialty products. Church & Dwight is publicly traded on the New York Stock Exchange under the ticker CHD and is headquartered in Ewing, New Jersey.

The company’s portfolio spans a range of categories including household cleaning and laundry, oral care, personal care, sexual wellness and health & wellness.

Recommended Stories

Insider Buying and Selling by Quarter for Church & Dwight (NYSE:CHD)

Receive News & Ratings for Church & Dwight Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Church & Dwight and related companies with MarketBeat.com's FREE daily email newsletter.

You might be interested in:

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Insider Selling: EuroDry (NASDAQ:EDRY) Director Sells $18,900.00 in Stock011.1312-08-2026
2Community Healthcare Trust (NYSE:CHCT) Director Acquires 8,000 Shares of Stock011.8812-08-2026
3Insider Selling: Pinterest (NYSE:PINS) Director Sells 46,875 Shares013.4312-08-2026
4Braveheart Bio (NASDAQ:BRVE) Director Erez Chimovits Acquires 1,940,000 Shares of Stock012.5312-08-2026
5Burke & Herbert Financial Services (NASDAQ:BHRB) Director James Mason Burke Sells 1,500 Shares011.4412-08-2026
6Insider Selling: Core Scientific (NASDAQ:CORZ) Insider Sells $199,700.00 in Stock011.1512-08-2026
7Insider Selling: Impinj (NASDAQ:PI) CFO Sells $264,365.00 in Stock011.8712-08-2026
8Globalstar (NASDAQ:GSAT) Director Sells $2,721,228.09 in Stock011.8512-08-2026
9Dianthus Therapeutics (NASDAQ:DNTH) SVP Adam Veness Sells 3,833 Shares of Stock011.1712-08-2026
10Dianthus Therapeutics (NASDAQ:DNTH) Director Simon Read Sells 2,777 Shares010.7712-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 12.91. Источник: www.themarketsdaily.com.